Atlas Trials

ATX-MS-1467 in Multiple Sclerosis

Clinical trial NCT01973491 · COMPLETED

Trial details

NCT number
NCT01973491
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2014-02-28
Primary completion
2016-04-30
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.